🟢 Surgepays is trading 8.3% up with no verified catalyst

Surgepays is trading at $0.15, up 8.30%, with no verified catalyst identified for the October 27 move.

• No confirmed new company-specific announcement explains the October 27 move; the GrowthLine launch was announced October 15, not today.
• Broader indexes were mixed in the supplied market context, and available evidence does not establish a broad-market cause.
• Volume was about 906,280 shares at 10:37 a.m. ET, well below the cited 19.54 million 65-day average.